Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,316 warrant series at 1,050 companies. 776 in the money, 59 expiring in the next 30 days, 30 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 2026 Warrants (May '26 Warrants, underwritten public offering) | $1.97 | $212.5M | 6-K EX-99.1, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2025 Warrants (November '25 Warrants, non-brokered private placement) | $1.97 | $212.5M | 6-K EX-99.1, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| KV Warrants | $2.38 | $209.6M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Other warrants (residual of 10-Q warrant table not attributable to KV Warrants) | $2.38 | $209.6M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| August 2024 private placement warrants (US$2.00, expiring August 15, 2027) | $2.04 | $208.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| February 2025 private placement warrants (US$3.66, expiring February 7, 2028) | $2.04 | $208.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| July 2025 registered direct placement agent (broker) warrants (US$3.588, expiring July 21, 2030) | $2.04 | $208.7M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants (GIBOW) – former BUJA SPAC warrants assumed under the Assignment, Assumption and Amendment Agreement | $82.85 | $208.4M | 20-F, May 15, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| June 2024 Pre-Funded Warrants (registered direct offering) | $5.31 | $205.9M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Private Placement Warrants — Sponsor (DynamixCore Holdings III, LLC) | $10.13 | $203.9M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Private Placement Warrants — Underwriters (CCM) | $10.13 | $203.9M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Public Warrants (included in IPO Units) | $10.13 | $203.9M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Credit facility warrants – vested ($0.40, expiring December 30, 2028) | $11.00 | $202.9M | 6-K EX-99.1, Oct 22, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| July 10, 2026 compensation (finders') warrants ($2.50, expiring December 31, 2026) | $11.00 | $202.9M | 6-K EX-99.1, Oct 22, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| July 10, 2026 unit warrants ($2.50, expiring December 31, 2026) | $11.00 | $202.9M | 6-K EX-99.1, Oct 22, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 12, 2026 compensation (finders') warrants ($2.50, expiring December 31, 2026) | $11.00 | $202.9M | 6-K EX-99.1, Oct 22, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 12, 2026 unit warrants ($2.50, expiring December 31, 2026) | $11.00 | $202.9M | 6-K EX-99.1, Oct 22, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| April 2026 Lind Class A Common Share Purchase Warrant | $2.25 | $202.3M | 6-K, Apr 7, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| November 2026 Lind Class A Common Share Purchase Warrant (Second Tranche) | $2.25 | $202.3M | 6-K, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| December 2023 Private Placement Warrants (exercise price C$1.70, expiring December 22, 2028) | $20.19 | $199.2M | 6-K EX-99.1, Aug 17, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Consultant warrant (August 25, 2020, 25,000 shares) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Consultant warrant (August 25, 2020, 3,643 shares) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Consultant warrant (March 31, 2020) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| H.C. Wainwright Placement Agent Warrants (January 2023 offering) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| H.C. Wainwright placement agent warrants (January 2025, October 2024 financing) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| January 2023 Common Warrants (remaining unexercised, repriced) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Late IPO Warrants (December 28, 2020) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Pre-Funded Warrant (RA Capital exchange, July 2026) | $1.40 | $195.7M | 4, Jul 31, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Pre-Funded Warrants (November 2025 underwritten offering) | $1.40 | $195.7M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Pre-Funded Warrants (October 2024 private placement) | $1.40 | $195.7M | 424B5, Dec 19, 2025Dilution tabAs of Nov 11, 2026 | ||||||||
| Series A-1 Warrants (October 2024 private placement) | $1.40 | $195.7M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series B Common Warrants (May 2024 offering) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series B-1 Warrants (October 2024 private placement) | $1.40 | $195.7M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series D Common Warrants (May 2024 inducement) | $1.40 | $195.7M | 10-K, Mar 26, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| HCR Warrants (First HCR Amendment, February 2026) | $1.39 | $195.5M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Lender Warrants (Loan Agreement, August 2022) | $1.39 | $195.5M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2026 Pre-Funded Warrants (October 2026 Private Placement) | $1.39 | $195.5M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Pre-funded warrants (2024, June 2025 and October 2025 series) — aggregate outstanding | $1.39 | $195.5M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| New Margin Warrant (Initial Closing, October 8, 2025) | $1.73 | $194.3M | 20-F, Apr 30, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| PIPE Warrants (August 2024 Convertible Note Purchase Agreement, Pine Mountain) | $1.73 | $194.3M | 10-Q, May 20, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| Private Warrants (INFINT SPAC private placement warrants) | $1.73 | $194.3M | 10-Q, May 20, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| Public Warrants (INFINT SPAC public warrants) | $1.73 | $194.3M | 10-Q, May 20, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| Amazon Warrant – tranche vested at issuance (Warrant Certificate AW-001) | $3.81 | $194.2M | SUPPL, Oct 8, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Agent's/finders' warrants – December 19, 2024 LIFE offering ($4.09, expiring December 19, 2029) | $1.27 | $192.7M | 6-K EX-99.1, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Finders' warrants – July 11, 2025 prospectus offering ($12.60, expiring July 11, 2030) | $1.27 | $192.7M | 6-K EX-99.1, Aug 14, 2026Dilution tabAs of Oct 31, 2026 | ||||||||
| Class A Warrants (February 2022 underwritten public offering) | $4.17 | $191.4M | 20-F, Apr 29, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Class B Warrants (March 2022 underwritten public offering) | $4.17 | $191.4M | 20-F, Apr 29, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Class C Warrants (May 2022 underwritten public offering) | $4.17 | $191.4M | 20-F, Apr 29, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Class D Warrants (June 2022) | $4.17 | $191.4M | 20-F, Apr 29, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Class E Warrants (August 2023 underwritten public offering) | $4.17 | $191.4M | 20-F, Apr 29, 2026Dilution tabAs of Nov 1, 2026 |
NGENNervGen Pharma Corp. Common stock$1.97Last price
May 2026 Warrants (May '26 Warrants, underwritten public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$212.5M
NGENNervGen Pharma Corp. Common stock$1.97Last price
November 2025 Warrants (November '25 Warrants, non-brokered private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$212.5M
SERVServe Robotics Inc.$2.38Last price
KV Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$209.6M
SERVServe Robotics Inc.$2.38Last price
Other warrants (residual of 10-Q warrant table not attributable to KV Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$209.6M
DGXXDigi Power X Inc.$2.04Last price
August 2024 private placement warrants (US$2.00, expiring August 15, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$208.7M
DGXXDigi Power X Inc.$2.04Last price
February 2025 private placement warrants (US$3.66, expiring February 7, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$208.7M
DGXXDigi Power X Inc.$2.04Last price
July 2025 registered direct placement agent (broker) warrants (US$3.588, expiring July 21, 2030)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$208.7M
GIBOGIBO Holdings Limited Class A Ordinary Shares$82.85Last price
Warrants (GIBOW) – former BUJA SPAC warrants assumed under the Assignment, Assumption and Amendment Agreement
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$208.4M
TRDAEntrada Therapeutics, Inc.$5.31Last price
June 2024 Pre-Funded Warrants (registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$205.9M
DNMXDynamix Corporation III Class A Ordinary Shares$10.13Last price
Private Placement Warrants — Sponsor (DynamixCore Holdings III, LLC)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$203.9M
DNMXDynamix Corporation III Class A Ordinary Shares$10.13Last price
Private Placement Warrants — Underwriters (CCM)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$203.9M
DNMXDynamix Corporation III Class A Ordinary Shares$10.13Last price
Public Warrants (included in IPO Units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$203.9M
PHOSFirst Phosphate Corp. Sponsored ADR$11.00Last price
Credit facility warrants – vested ($0.40, expiring December 30, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$202.9M
PHOSFirst Phosphate Corp. Sponsored ADR$11.00Last price
July 10, 2026 compensation (finders') warrants ($2.50, expiring December 31, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$202.9M
PHOSFirst Phosphate Corp. Sponsored ADR$11.00Last price
July 10, 2026 unit warrants ($2.50, expiring December 31, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$202.9M
PHOSFirst Phosphate Corp. Sponsored ADR$11.00Last price
June 12, 2026 compensation (finders') warrants ($2.50, expiring December 31, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$202.9M
PHOSFirst Phosphate Corp. Sponsored ADR$11.00Last price
June 12, 2026 unit warrants ($2.50, expiring December 31, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$202.9M
OWLSOBOOK Holdings Inc.$2.25Last price
April 2026 Lind Class A Common Share Purchase Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$202.3M
OWLSOBOOK Holdings Inc.$2.25Last price
November 2026 Lind Class A Common Share Purchase Warrant (Second Tranche)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$202.3M
DRUGBright Minds Biosciences Inc.$20.19Last price
December 2023 Private Placement Warrants (exercise price C$1.70, expiring December 22, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$199.2M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Consultant warrant (August 25, 2020, 25,000 shares)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Consultant warrant (August 25, 2020, 3,643 shares)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Consultant warrant (March 31, 2020)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
H.C. Wainwright Placement Agent Warrants (January 2023 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
H.C. Wainwright placement agent warrants (January 2025, October 2024 financing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
January 2023 Common Warrants (remaining unexercised, repriced)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Late IPO Warrants (December 28, 2020)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Pre-Funded Warrant (RA Capital exchange, July 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Pre-Funded Warrants (November 2025 underwritten offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Pre-Funded Warrants (October 2024 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Series A-1 Warrants (October 2024 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Series B Common Warrants (May 2024 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Series B-1 Warrants (October 2024 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
IKTInhibikase Therapeutics, Inc.$1.40Last price
Series D Common Warrants (May 2024 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.7M
ADCTADC Therapeutics SA$1.39Last price
HCR Warrants (First HCR Amendment, February 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.5M
ADCTADC Therapeutics SA$1.39Last price
Lender Warrants (Loan Agreement, August 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.5M
ADCTADC Therapeutics SA$1.39Last price
October 2026 Pre-Funded Warrants (October 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.5M
ADCTADC Therapeutics SA$1.39Last price
Pre-funded warrants (2024, June 2025 and October 2025 series) — aggregate outstanding
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$195.5M
CURRCurrenc Group Inc. Ordinary Shares$1.73Last price
New Margin Warrant (Initial Closing, October 8, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$194.3M
CURRCurrenc Group Inc. Ordinary Shares$1.73Last price
PIPE Warrants (August 2024 Convertible Note Purchase Agreement, Pine Mountain)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$194.3M
CURRCurrenc Group Inc. Ordinary Shares$1.73Last price
Private Warrants (INFINT SPAC private placement warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$194.3M
CURRCurrenc Group Inc. Ordinary Shares$1.73Last price
Public Warrants (INFINT SPAC public warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$194.3M
ELVAElectrovaya Inc.$3.81Last price
Amazon Warrant – tranche vested at issuance (Warrant Certificate AW-001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$194.2M
BTQBTQ Technologies Corp.$1.27Last price
Agent's/finders' warrants – December 19, 2024 LIFE offering ($4.09, expiring December 19, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$192.7M
BTQBTQ Technologies Corp.$1.27Last price
Finders' warrants – July 11, 2025 prospectus offering ($12.60, expiring July 11, 2030)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$192.7M
IMPPImperial Petroleum Inc. Common Shares$4.17Last price
Class A Warrants (February 2022 underwritten public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$191.4M
IMPPImperial Petroleum Inc. Common Shares$4.17Last price
Class B Warrants (March 2022 underwritten public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$191.4M
IMPPImperial Petroleum Inc. Common Shares$4.17Last price
Class C Warrants (May 2022 underwritten public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$191.4M
IMPPImperial Petroleum Inc. Common Shares$4.17Last price
Class D Warrants (June 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$191.4M
IMPPImperial Petroleum Inc. Common Shares$4.17Last price
Class E Warrants (August 2023 underwritten public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$191.4M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,056 dilution snapshots. 4,860 of 5,316 series state an exercise price and 3,372 an expiry date. 58 record when exercise begins; that count grows as companies are re-extracted. 622 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.